| abstract |
A 3,7-diaminophenothiazine compound (DAPTZ) in a reduced crystalline form stable for use in a method of treatment or prophylaxis of a cognitive or CNS disorder in a patient, wherein said disorder is one that is susceptible to treatment. by said DAPTZ compound, a method comprising administering to said patient orally a unit dose containing said DAPTZ compound as an active ingredient, wherein the patient is someone who has been evaluated as having a hematological disorder, the effects of said Hematological disorder can be aggravated, on the other hand, due to the DAPTZ compound. |